Compounds > propiolactone

propiolactone and Respiratory Syndrome, Acute, Severe

propiolactone has been researched along with Respiratory Syndrome, Acute, Severe in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baras, B; Chen, J; Goossens, G; Knott, I; Lamirande, EW; Roberts, A; Subbarao, K; Vassilev, V; Vogel, L; Ward, JM1
Abrignani, S; Becker, S; Eickmann, M; Klenk, HD; Kolesnikova, L; Murphy, B; Rappuoli, R; Roberts, A; Stadler, K; Subbarao, K; Vogel, L1

Other Studies

2 other study(ies) available for propiolactone and Respiratory Syndrome, Acute, Severe

ArticleYear
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
    Viral immunology, 2010, Volume: 23, Issue:5

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Neutralizing; Antibodies, Viral; Cricetinae; Disinfectants; Female; Immunization, Secondary; Liver; Lung; Mesocricetus; Mice; Mice, Inbred BALB C; Propiolactone; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Survival Analysis; Vaccination; Vaccines, Inactivated; Viral Vaccines; Virus Inactivation

2010
SARS vaccine protective in mice.
    Emerging infectious diseases, 2005, Volume: 11, Issue:8

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Immunization; Mice; Mice, Inbred BALB C; Propiolactone; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vaccines, Attenuated; Vaccines, DNA; Viral Vaccines; Virus Replication

2005